Sgltr-V Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Remogliflozin Etabonate (100mg) + Vildagliptin (50mg)
Overview Sgltr-V Tablet
The dual-action Sgltr-V Tablet aids in managing type 2 diabetes in adults 18 and older. It enhances blood sugar regulation, particularly when other treatments prove insufficient. This medication may be used independently or alongside other diabetes therapies, always complemented by a healthy diet and regular physical activity. For optimal results, take as directed—typically twice daily—maintaining consistent timing. Discontinue use only under your physician's guidance. Sgltr-V Tablet helps regulate blood glucose, potentially mitigating future complications. Continued adherence to your doctor's dietary and exercise plan is crucial. Lifestyle significantly impacts diabetes management. Common side effects can include gastrointestinal upset (diarrhea, nausea, vomiting), stomach discomfort, and headaches. Concurrent use with insulin or sulfonylureas may increase hypoglycemia risk; learn to identify and address this. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, as well as pregnancy or breastfeeding. Disclose all medications to ensure safe interaction with Sgltr-V. Alcohol consumption should be minimized due to its potential to lower blood sugar. Your doctor will monitor kidney function and blood glucose levels throughout treatment.
Primary Ingredients of Sgltr-V Tablet
No information provided. Please provide the text you wish me to rewrite.
Uses of Sgltr-V Tablet
Managing type 2 diabetes
Major Benefits of Sgltr-V Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sgltr-V Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Sgltr-V Tablet:
- Diarrhea
- Nausea
- Headache
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Weight gain
- Fever
- Cough
- Ketonuria
- Constipation
- Dyslipidemia
- Hypotension (low blood pressure)
- Weakness
- Urinary tract infection
- Respiratory tract infection
- Decreased estimated glomerular filtration rate
How to use Sgltr-V Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sgltr-V Tablets can be consumed with or without food, although consistent timing is recommended.
How Sgltr-V Tablet works:
Sgltr-V tablets contain Remogliflozin Etabonate and Vildagliptin, two medications that work together to manage diabetes. Remogliflozin Etabonate helps the body eliminate excess glucose via the urine, while Vildagliptin stimulates insulin production by the pancreas and reduces counter-regulatory hormones. The combined effect lowers both fasting and postprandial blood glucose.
SAFETY ADVICE
AlcoholCAUTION
Use of Sglt2 inhibitors like Sgltr-V Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Sglt2 inhibitor tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Sglt2 inhibitor use while breastfeeding are unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Sgltr-V Tablet use.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Sgltr-V Tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Sgltr-V tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Sgltr-V Tablet :
Should you forget a Sgltr-V Tablet dose, administer it promptly. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Sgltr-V Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



